Analysis originally distributed on July 13, 2017 By: Michael Vodicka of Cannabis Stock Trades
There are millions of square feet of cannabis cultivation facilities being built all across North America.
Take Americann (OTC:ACAN) for example. Americann is a U.S. based cannabis company headquartered in Massachusetts. Americann is in the early stages of building a 1 million square foot cultivation facility in Mass that will potentially serve as the primary cultivation hub to supply a huge portion of the Eastern cannabis market.
Cronos Group (CDNX:MJN.V) is another good example. Cronos is a Canadian cannabis company headquartered in Toronto. In May, Cronos announced that one of the companies it owns, Peace, had broke ground on a 315,000 square foot cultivation facility.
This project will include a 286,000 square foot production facility, a 28,000 square foot greenhouse, and a 1,200 square foot extraction laboratory.
When finished, this facility is expected to be one of the largest indoor cannabis production facility in the world.
As you can see, cannabis companies are in the process of hugely ramping up their cultivation capacities to meet the tidal wave of demand for cannabis coming down the pike.
One way to profit is to simply invest in the companies building these cultivation facilities. That could turn out to be extremely profitable.
However, I have an even better way to potentially profit. Continue reading "More To Come For This Cannabis Lighting Company?"
Analysis originally distributed on July 05, 20176 By: Michael Vodicka of Cannabis Stock Trades
Three weeks ago I wrote about Mexican President Enrique Pena Nieto signing a bill legalizing the use of medicinal cannabis THC, CBD, and all cannabis derivatives. The new legislation also makes it legal to produce and distribute cannabis for medical and therapeutic purposes.
This week, the global trend of cannabis legalization continues in the U.S.
On July 1, Nevada became the fifth U.S. state to legalize recreational cannabis.
This is going to be another huge cannabis market, fueled by the tens of millions of tourists that visit Las Vegas every year.
To get the latest analysis as soon as it is released, please subscribe to our free weekly newsletter.
Right out of the chute, demand is already blowing past expectations. Continue reading "Nevada Becomes Fifth State to Legalize Cannabis - Here's How you Can Profit"
Analysis originally distributed on June 21, 2017 By: Michael Vodicka of Cannabis Stock Trades
Legal cannabis scored another big victory this week.
In April, Mexico's lower parliament overwhelmingly voted to legalize medical cannabis, voting 357 to 7.
Then, earlier this week, Mexico's President Enrique Pena Nieto signed the bill into law, legalizing the use of medicinal cannabis THC, CBD, and all cannabis derivatives. The new legislation also makes it legal to produce and distribute cannabis for medical and therapeutic purposes.
Early estimates project sales between $1 billion and $2 billion in the first 10 years. That would come out to between $100 and $200 million per year.
The size of Mexico's young cannabis market will pale in comparison to the US and Canada.
In 2016, US cannabis sales totaled $6.5 billion. Continue reading "Mexico Legalizes Medical Cannabis - Here's How You Can Profit"
Analysis originally distributed on June 15, 2017 By: Michael Vodicka of Cannabis Stock Trades
In the old days, pot was seen as a way to get stoned.
But now, researchers are discovering that pot can actually have many health benefits.
Most of those come from Cannabidiol - one of the most prevalent compounds found in hemp plants that is commonly refereed to as CBD on the Street.
Studies have shown that the non-psychoactive elements of CBD can deliver relief to a wide range of ailments, including aches, pains, anxiety, insomnia and arthritis - without the euphoric effects provided by THC.
These benefits are creating a huge growth market.
The Hemp Business Journal, a CBD media and data company, estimates the CBD market will grow to $2.1 billion in consumer sales by 2020. That would be a 700% increase from 2016.
This is an exciting segment of the cannabis industry that doesn't get a lot of attention. Continue reading "Secret CBD Company Grows Sales 1,300% in 12 Months"
Analysis originally distributed on June 7, 2017 By: Michael Vodicka of Cannabis Stock Trades
Blockbuster drugs are the holy grail of the pharmaceutical and biotech industry.
When annual sales of a new drug break the $1 billion mark, investors are usually rewarded with big gains.
This is what began happening late 2012 with Gilead Science (NASDAQ:GILD).
In 2013 the FDA approved Gilead's hepatitis C drug Sovaldi.
Then, in 2014, Gilead scored an FDA approval for another Hep C drug, Harvoni.
Both drugs went on to quickly hit blockbuster status - sending shares of Gilead soaring - jumping more than 200% in the next two years. Take a look below.
Image courtesy of MarketClub.com
Today, the young cannabis industry is in hot pursuit of its first ever cannabis blockbuster - and I expect the winner of this race to deliver huge gains to shareholders. Continue reading "A 2nd Cannabis Stock With $1 Billion Drug Potential"